TORONTO, March 22, 2016 /CNW/ – Apotex Inc. announced today that it has launched the first generic version of Merck’s Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.  

Apotex’s mometasone furoate nasal spray is a once-daily anti-allergen…